This review reveals the link between gut-brain axis dysregulation and neuropsychiatric disorders, suggesting therapeutic targets.
Accumulating evidence highlights the crucial role of the gut-brain axis in diseases. This bidirectional signaling connects the gastrointestinal tract (GI) and the brain via neural, immune, and endocrine pathways, orchestrating a range of physiological processes. Dysregulation of the gut-brain axis has been related to a variety of neuropsychiatric, neurodegenerative, and neurodevelopmental disorders, as well as to disturbances in emotional regulation, cognition, and feeding-related conditions. The complex molecular interactions underlying this axis are necessary for maintaining homeostasis and overall health. Emerging pharmacological interventions and therapeutic targets have demonstrated potential in modulating gut-brain signaling to influence disease outcomes. This review provides a comprehensive view of the gut-brain axis, detailing its pivotal role in disease pathogenesis and exploring its therapeutic relevance.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: